Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2017 1
2018 2
2019 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
Baselga E, Dembowska-Baginska B, Przewratil P, González-Enseñat MA, Wyrzykowski D, Torrelo A, López Gutiérrez JC, Rychłowska-Pruszyńska M, de Lucas-Laguna R, Esteve-Martinez A, Roé E, Zaim M, Menon Y, Gautier S, Lebbé G, Bouroubi A, Delarue A, Voisard JJ. Baselga E, et al. Among authors: bouroubi a. Pediatrics. 2018 Sep;142(3):e20173866. doi: 10.1542/peds.2017-3866. Epub 2018 Aug 6. Pediatrics. 2018. PMID: 30082451 Clinical Trial.
Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia.
Schneider H, Hadj-Rabia S, Faschingbauer F, Bodemer C, Grange DK, Norton ME, Cavalli R, Tadini G, Stepan H, Clarke A, Guillén-Navarro E, Maier-Wohlfart S, Bouroubi A, Porte F. Schneider H, et al. Among authors: bouroubi a. Genes (Basel). 2023 Jan 6;14(1):153. doi: 10.3390/genes14010153. Genes (Basel). 2023. PMID: 36672894 Free PMC article.
Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U, Issiakhem Z, Gautier S, Kottner J, Wigger-Alberti W, Fischer T, Hoffmann R, Tonner F, Bouroubi A, Voisard JJ. Blume-Peytavi U, et al. Among authors: bouroubi a. J Cosmet Dermatol. 2019 Feb;18(1):215-220. doi: 10.1111/jocd.12541. Epub 2018 Apr 16. J Cosmet Dermatol. 2019. PMID: 29659116 Clinical Trial.